Access cutting-edge cancer treatment through this clinical trial at a research site in Lebanon. Study-provided care at no cost to qualified participants.
Access cancer specialists in Lebanon at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
Lung cancer is by far the leading cause of cancer death among both men and women worldwide and the second most common cancer in terms of new cases. Small cell lung cancer (SCLC) is the deadliest form of lung cancer. The standard first-line treatment is the combination of carboplatin, etoposide, and atezolizumab. While response rates for this regimen are high (roughly 60%), the duration of response is short, typically 4 months. Following progression after the 1st line treatment of SCLC, there is
Sponsor: UNC Lineberger Comprehensive Cancer Center
Check if you qualify for this cancer clinical trial in Lebanon, NH
If you're searching for cancer treatment options in Lebanon, NH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lebanon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.